Current Research Funding

James Bailey, M.D.

  • Healthy Memphis Common Table Sub award 6/1/2008 – 5/31/2011

Laura Carbone, M.D.

  • ACR REF Fellowship Training 2010-2011
  • Bristol Myers – Fellowship Award
  • Centocor-Fellowship Award 7/1/09-6/30/10

Merit Review

  • Health Services Merit Review 4-1-09 through 3-31-12; multi-site funding on her Merit

David D. Brand , PhD

Merit Review

  • funded for 10-1-07 thru 9-30-10

Harry Courtney, Ph.D.

  • Univ. of Memphis- subaward from the US Army 4/29/08-4/29/10

Merit Review

  • 10-1-08 through 9-31-12

Samuel Dagogo-Jack, M.D.

  • Case Western Reserve University – sub award 3/1/08-2/28/16
  • American Diabetes Assoc. Fellowship award 7/1/08-6/30/10
  • NIH Pathobiology of Prediabetes in A Bi-Racial Cohort 4/1/06-3/31/11

James Dale, M.D.

  • NIH - 17th Lancefield International Symposium -3/15/08-2/28/09
  • NIH – Chemistry of Immunology of Streptococcal M Proteins -6/1/96-5/31/11
  • NIH – Vaccine prevention of Rheumatic Fever 9/1/04-8/31/11

Merit Review

  • Expired Merit Review 10-1-00 thru 9-30-05, NOT submitted for renewal

Parnab Das, M.D.

  • University of Toledo-CORAL 3/31/10

Marion Dugdale

  • Univ. of N. Carolina –sub award Prevention of the Complication of bleeding Disorder 9/30/08-9/29/10
  • Univ. of N. Carolina – sub award-Comprehensive Hemophilia Diagnostic & Treatment Ctr. 6/1/08-5/31/10
  • State of Tennessee Hemophilia Clinic-7/1/08-6/30/10

Jaquelyn Fleckenstein, M.D.

  • Core – Clinical Facility 2006

James Fleckenstein, M.D.

Merit Review

  • 10-1-09 thru 9-30-12

Ivan Gerling, Ph.D.

  • NIH - Molecular Phenotyping of NOD Mice 7/1/02-3/31/11

Lisa Jennings, Ph.D.

  • Astrazeneca – Reduction of Arterial Thrombosis & Thrombus Stability 9/11/08
  • Univ. of Memphis –sub award from US Army – 4/29/08-4/28/10

Andrew Kang, M.D.

  • NIH supplement – Suppression of Collagen Induced Arthritis with Altered Peptide Ligands 9/1/09 – 8/31/11

Merit Review

  • 1-1-04 thru 12-31-08

Abbas Kitabchi, M.D.

  • NIH – Diabetes Prevention Program Outcomes Study Phase 2 – 8/20/94 – 1/31/14
  • Univ. of TX San Antonio sub award – 2/1/09-1/31/1

Charles Mansbach, M.D.

  • NIH – A Cell biological Approach to Lipid Absorption – 5/1/06-4/30/11

Gianfranco U. Meduri, M.D.

Merit Review

  • Investigator initiated CSP Study; 5 year $ 20 M not yet fully funded

Arnold Postlethwaite, M.D.

  • NIH – Research Training in Connective Tissue Diseases – 9/20/78-4/30/10

Merit Review

  • Active Merit Review 4-1-07 thru 3-31-11. Clinical Merit Review submitted 10-1-08 through 9-30-12; (two Merits one clinical, one basic science)

Kodangudi B. Ramanathan, MD

Merit Review

  • VA Cooperative Studies Program (CSP) - CSP #399, #424, #499, #442, clinical trials. Pharma Studies

Guy Reed, M.D.

  • NIH – Plasminogen Activation & SK: Structure-Function – 7/1/98-5/31/13

Ed Rosloniec, Ph.D.

  • Arthritis Foundation – Engineered Treg Cells for the Treatment of Autoimmune Arthritis 9/1/08-8/31/10

Merit Review

  • 10-1-06 thru 09-30-10

Shadab Siddiqi, Ph.D.

  • NIH – A Cell Biological Approach to Hepatic Lipid Metabolism – 7/1/08-7/31/09

Scott Sinclair, M.D.

  • NIH – Stretch & Hyperoxia in Ventilator-induced Lung Injury – 7/5/06-5/31/11
  • NIH supplement – 7/1/09-6/30/11

Solomon Solomon, M.D.

  • NIH – Short-Term Research Training for Medical Students – 6/1/1980-5/31/2010

Merit Review

  • Expired Merit Review 4-1-99 thru 3-31-04, renewal re-submitted 9-15-07

John M. Stuart, MD

Merit Review

  • 1. Active Merit Review 4-1-07 thru 3-31-11. 2. Active Research Enhancement Award Program (REAP) 10-1-03 thru 9-30-09

Yao Sun, M.D.

  • NIH – Oxidative Stress & Myocardial Remodeling Following MI – 7/1/05-6/30/10

Barry M. Wall, M.D.

Merit Review

  • CSP 565 VA Nephropathy in Diabetes Study

Karl Weber, M.D.

  • NIH – Aldosteronism: An Immunostimulatory State – 9/17/04 -7/31/09
  • NIH – Recovery from Cachexia in Heart & Skeletal Muscle – 7/14/08-6/30/12

Beverly Williams-Cleaves

  • New York Medical College GSK Subcontract - 4/1/08-3/31/10
  • Lilly Research Labs-B9R-MC-GDGA – 3/7/08-3/6/11

Feng Zhang

  • American Heart Association – Post Doc Fellowship Award – 7/1/09-6/30/11

Xin Zhang, M.D.

  • NIH – Molecular Mechanism of KAI1/CD82-medicated Suppression – 3/1/04-2/28/10